ArticleGels (Basel, Switzerland)2025
Construction of PdCu Alloy Decorated on the N-Doped Carbon Aerogel as a Highly Active Electrocatalyst for Enhanced Oxygen Reduction Reaction.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Next-Generation Aerogel Electrocatalysts for Oxygen Reduction Reaction.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Engineering Gel-Based Precursors into Advanced ORR Catalysts for Zn-Air Batteries and Fuel Cells: Insights into Hydrogels, Aerogels, Xerogels, Metal-Organic Gels, and Metal Aerogels.Gels (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Fuel cells/zinc-air cells represent a transformative technology for clean energy conversion, offering substantial environmental benefits and exceptional theoretical efficiency. However, the high cost and limited durability of platinum-based catalysts for the sluggish oxygen reduction reaction (ORR) at the cathode severely restrict their scalability and practical application. To address these critical challenges, this study explores a groundbreaking approach to developing ORR catalysts with enhanced performance and reduced costs. We present a novel Pd
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.